| Jan 09 |
Swiss drug company’s botched bottles may threaten American consumersDo you feel safe when it comes to the drugs you buy to protect your health? If so, maybe you shouldn’t. Maybe wariness is more fitting when you focus on pharmaceuticals.
Take this outrage from Swiss drug maker Novartis. It’s recalling some containers of Bufferin, NoDoz, Excedrin and Gas-X due to worries that they may have broken or chipped tablets or random pills from other medicines. (more…) |
| Apr 27 |
Defective drug Seroquel spurs $520 million fine; lawsuits remain
Does all this sound familiar? If so, it should. In just three years, that makes four enormous pharmaceutical companies which have paid large fines for illegally marketing antipsychotic drugs, which for them is a hugely profitable arena. |
London-based pharmaceutical giant AstraZeneca has agreed to pay a $520 million fine exacted by the U.S. Department of Justice for illegally marketing antipsychotic drug Seroquel by overstating the drug’s purposes and failing to alert users of its health risks.